Bowel cancer screening is identifying approximately 100 cancers every week among people in their 50s in England, according to the latest annual figures published by NHS England. The data, which covers the period from April 2024 to March 2025, also shows that this age group participates in screening at lower rates than older cohorts — a gap the health service is now actively working to address.
Participation Rates Among Those in Their 50s
Of all the age groups eligible for bowel cancer screening, people in their 50s were among the least likely to return their home testing kits during the reporting period. NHS England's annual bowel screening figures recorded that just 56.2% of 54-year-olds completed the screening process in 2024–25. That means roughly four in ten individuals in this specific age bracket did not participate, leaving a substantial portion of the population unscreened during the year.
The figures highlight a persistent pattern: uptake among those newly eligible for screening — who tend to be in their early-to-mid 50s — lags behind that seen in older age groups who may have greater familiarity with the programme.
What the Screening Programme Involves
Bowel cancer screening in England is offered to eligible adults and involves a home-based stool testing kit, known as a faecal immunochemical test (FIT). The kit is sent by post, completed at home, and returned by mail for laboratory analysis. Abnormal results prompt further investigation, typically a colonoscopy.
The programme is designed to detect bowel cancer at an earlier stage, when treatment outcomes are generally more favourable. The fact that around 100 cancers per week are being found among people in their 50s alone underscores the volume of disease the programme is identifying — and, by implication, the potential consequences of non-participation.
Why the 50s Age Group Matters
Bowel cancer is one of the most commonly diagnosed cancers in the United Kingdom. Incidence rises with age, and the 50s represent a critical window during which early-stage disease may be present without producing noticeable symptoms. Screening programmes are specifically structured to capture this pre-symptomatic phase.
NHS England's appeal to people in this age group reflects a concern that lower participation rates may mean cancers are being missed — or caught at a later, harder-to-treat stage — among a population that is statistically at meaningful risk.
Barriers to Participation
Research into bowel cancer screening uptake has identified several recurring barriers. Awareness of the programme, concerns about the testing process, and a general reluctance to engage with health services in the absence of symptoms have all been cited in the literature as factors that reduce participation rates. Socioeconomic deprivation and ethnicity have also been associated with lower uptake in prior studies, though NHS England's latest release focuses on the age-specific gap rather than these broader determinants.
The relatively modest majority — just over half of 54-year-olds — who completed screening in 2024–25 suggests that awareness and engagement campaigns face a substantial challenge in shifting behaviour within this group.
Context Within the Broader Programme
The NHS bowel cancer screening programme has been gradually expanding its eligible age range in recent years, with the intention of reaching people earlier in the disease's potential development. The detection of roughly 100 cancers per week among those in their 50s is, in part, a product of that expansion — but it also reflects the underlying prevalence of the disease in this demographic.
NHS England's publication of these figures serves as both a progress report and a call to action directed at those who have received but not yet returned a screening kit. The data indicates that the programme is functioning as an effective detection tool where it is used; the challenge, according to the figures, lies in closing the participation gap.